Position in VCYT
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$259,065
-$1,955 QoQ
Shares Held
8,043
+29.7% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VCYT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Cornerstone Investment Partners, LLC holds $120,688,418 across 6 Diagnostics & Research names. VCYT ranks #5 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IQV |
Iqvia Holdings Inc.
|
433,478 | $73,925,338 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
92,313 | $45,374,608 | |
| 3 | CRL |
Charles River Laboratories International, Inc.
|
3,594 | $619,965 | |
| 4 | BLLN |
BillionToOne, Inc.
|
3,402 | $268,553 | |
| 5 | VCYT |
Veracyte, Inc.
This page
|
8,043 | $259,065 | |
| 6 | WGS |
GeneDx Holdings Corp.
|
3,751 | $240,889 |
All Filings in VCYT
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $259,065 | 8,043 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $261,020 | 6,200 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $212,708 | 6,196 | Shares | Sole | 2025-11-06 | |
| 2024-12-31 | $286,624 | 7,238 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $246,245 | 7,234 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||